Antibody Production Market to reach USD 36.49 billion by 2032 at a CAGR of 10.95%
The antibody production is experiencing a surge in demand which is driven by factors like the rising prevalence of chronic diseases like cancer, autoimmune disorders, increasing adoption of targeted therapies, and a growing focus on R&D in the pharmaceutical and biotechnology sectors. The process of antibody production can take eight weeks or more due to numerous steps with potential delays and challenges. From outsourcing gene synthesis to subcloning, transfection, cell culture, and purification, each stage introduces roadblocks. Choosing the right cell line and optimizing purification based on specific antibody properties add further complexity.